2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery

Eisenberg, Dan; Shikora, Scott A.; Aarts, Edo O.; Aminian, Ali; Angrisani, Luigi; Cohen, Ricardo V.; Luca, Maurizio De; Faria, Sílvia Leite; Goodpaster, Kasey; Haddad, Ashraf; Himpens, Jacques; Kow, Lilian; Kurian, Marina; Loi, Ken; Mahawar, Kamal; Nimeri, Abdelrahman; O’Kane, Mary; Papasavas, Pavlos; Ponce, Jaime; Pratt, Janey; Rogers, Ann M.; Steele, Kimberley E.; Suter, Michel; Kothari, Shanu N.

doi:10.1016/j.soard.2022.08.013

Cited by 338 publications

(199 citation statements)

References 137 publications

Supporting

Mentioning

129

Contrasting

Unclassified

Order By: Relevance

“…Therefore, bariatric surgery has become a treatment option for long-term weight loss among patients with morbid obesity and those unable to adopt dieting [ 2 ]. The bariatric clinic in King Fahad General Hospital (KFGH), Jeddah, Saudi Arabia, follows the American Society for Metabolism and Bariatric Surgery, which recommends surgery for patients who have BMI ≥40 and BMI ≥35 with at least one obesity-related co-morbidities (such as type II diabetes, hypertension, and obstructive sleep apnea), or patients can't achieve a healthy weight loss sustained for a period of time with prior weight loss efforts [ 3 ]. The main aim of bariatric surgery and especially gastric sleeve surgery, also known as metabolic surgery, is to reduce gastric capacity and the absorption surface area of the gastrointestinal tract.…”

Section: Introductionmentioning

confidence: 99%

Prevalence of Dumping Syndrome and Its Determinants Among Post-Bariatric Surgery Adult Patients at King Fahad General Hospital, Jeddah, 2019–2020

Alsulami¹,

Fathaldin²,

Alghamdi³

et al. 2022

Cureus

View full text Add to dashboard Cite

BackgroundBariatric surgery is one of the most effective interventions for morbid obesity. Despite its benefits, unwanted consequences such as dumping syndrome (DS) have been reported following the procedure. This study aims to estimate the prevalence of DS and identify the factors associated with it in Saudi Arabia. MethodologyThis cross-sectional study collected data from patients who underwent bariatric surgery at King Fahad General Hospital, Jeddah, Saudi Arabia, in 2019-2020. A validated questionnaire was used to collect the data. The questionnaire included demographic items such as age and sex and items relating to DS such as nausea, vomiting, and palpitations. A modified version of the Sigstad diagnostic scoring system was used to confirm the diagnosis. ResultsOf the 240 investigated cases, two-thirds (67.5%) were females. The most reported symptoms were nausea (37.9%), vomiting (36.7%), desire to lie down (25.5%), restlessness (25.5%), and abdominal fullness (23.7%). Based on the modified Sigstad diagnostic scoring system, 75 (31.4%) patients met the criteria for DS. The bivariate analysis showed the prevalence was significantly higher in females (36.4%), those with university qualifications (40.3%), and those with high monthly income (62.5%) (p<0.05). Also, dietary behaviors in terms of frequency, size of meals, and drinking liquids with meals were significantly associated with the prevalence of DS, where the lowest prevalence was recorded among those who ate more than one small meal (10.9%), while the highest prevalence was found in those who ate more than one large meal (81.8%); also, the prevalence was significantly higher in patients who drank liquids with meals (40.8%) than those who drank liquids between meals (26.8%) (p<0.05). ConclusionIn this single institutional study, we report a 31.4% prevalence of DS among our cohort. The predictors of the syndrome include gender, education level, monthly income, eating more than one large meal per day, and drinking liquids with meals. In the future, these predictors will be explained to patients before and after bariatric surgery to reduce the prevalence of such inconvenient syndromes.

show abstract

Section: Introductionmentioning

confidence: 99%

Prevalence of Dumping Syndrome and Its Determinants Among Post-Bariatric Surgery Adult Patients at King Fahad General Hospital, Jeddah, 2019–2020

Alsulami¹,

Fathaldin²,

Alghamdi³

et al. 2022

Cureus

View full text Add to dashboard Cite

show abstract

“…The American Society for Metabolic and Bariatric Surgery (ASMBS) and the International Federation for Surgery of Obesity and Metabolic Disorders (IFSO) [65] recently released new guidelines focused on the indications for bariatric and metabolic surgery, which include lower thresholds for both the Asian population similar to the Asian-Pacific recommendations and general population. With the recent joint release of the updated guidelines from ASMBS and IFSO, best practices would include the recommended lower BMI threshold of ≥ 30 for the general population for consideration of bariatric and metabolic surgery and ≥ 25 for [32] n=79…”

Section: Discussionmentioning

confidence: 99%

A Systematic Review on Participant Diversity in Clinical Trials—Have We Made Progress for the Management of Obesity and Its Metabolic Sequelae in Diet, Drug, and Surgical Trials

Johnson-Mann

Cupka

et al. 2022

J. Racial and Ethnic Health Disparities

View full text Add to dashboard Cite

Objective Individuals from Black and Hispanic backgrounds represent a minority of the overall US population, yet are the populations most affected by the disease of obesity and its comorbid conditions. Black and Hispanic individuals remain underrepresented among participants in obesity clinical trials, despite the mandate by the National Institutes of Health (NIH) Revitalization Act of 1993. This systematic review evaluates the racial, ethnic, and gender diversity of clinical trials focused on obesity at a national level. Methods Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic review of clinicaltrials.gov, PubMed, Cochrane Central, and Web of Science was undertaken to locate phase 3 and phase 4 clinical trials on the topic of obesity that met associated inclusion/exclusion criteria. Ultimately, 18 studies were included for review. Results White non-Hispanic individuals represented the majority of clinical trial participants, as did females. No study classified participants by gender identity. Reporting of race/ethnicity was not uniform, with noted variability among racial/ethnic subgroups. Conclusions Our findings suggest that disparities remain in the diverse racial, ethnic, and gender representation of participants engaged in clinical trials on obesity relative to the prevalence of obesity in underrepresented populations. Commitment to inclusive and intentional recruiting practices is needed to increase the representation of underrepresented groups, thus increasing the generalizability of future research.

show abstract

“…The dominant bariatric surgical procedures are sleeve gastrectomy and Roux-en-Y gastric bypass, accounting for approximately 90% of all operations worldwide [29]. Bariatric surgery is considered an effective treatment option for severe obesity, resulting in efficient and sustained weight loss and a reduction in obesity-associated comorbidities such as type 2 diabetes, and hypertension [29][30][31]. Bariatric surgery may also be associated with a lower risk of kidney function decline and may prevent and slow the progression of chronic kidney disease in severely obese patients [32].…”

Section: Bariatric Surgery-therapy or Risk?mentioning

confidence: 99%

Dietary weight loss strategies for kidney stone patients

Siener

Metzner

2023

World J Urol

View full text Add to dashboard Cite

Purpose Overweight has been associated with an increased risk of incident and recurrent kidney stone disease. Weight reduction is the therapeutic consequence to decrease the risk of stone formation. This review examines the effectiveness of different weight loss strategies on weight reduction and cardiometabolic risk profile, with a particular focus on risk factors for urolithiasis. Methods A selective literature search was performed using PubMed and Cochrane library. Results Clinical evidence for the potential benefits of dietary weight loss strategies for kidney stone disease is limited. A conventional, energy-restricted diet may significantly induce weight loss and reduce urinary supersaturation of calcium oxalate in overweight individuals with or without a history of stone formation. The current data indicate that an energy-restricted diet with partial meal replacement may additionally decrease the relative supersaturation of uric acid and further improve the cardiometabolic risk profile, and, thus, may be a favourable option for overweight kidney stone patients. Studies on the Mediterranean and DASH diets on the association between weight loss and the risk of urinary stone formation are lacking. Conclusion An energy-restricted diet with or without meal replacement could be a promising weight loss strategy for overweight kidney stone patients. Further studies are needed to evaluate the impact of different weight loss strategies on urinary risk factors and cardiometabolic risk profile in urolithiasis.

show abstract

2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery

Cited by 338 publications

References 137 publications

Prevalence of Dumping Syndrome and Its Determinants Among Post-Bariatric Surgery Adult Patients at King Fahad General Hospital, Jeddah, 2019–2020

Prevalence of Dumping Syndrome and Its Determinants Among Post-Bariatric Surgery Adult Patients at King Fahad General Hospital, Jeddah, 2019–2020

A Systematic Review on Participant Diversity in Clinical Trials—Have We Made Progress for the Management of Obesity and Its Metabolic Sequelae in Diet, Drug, and Surgical Trials

Dietary weight loss strategies for kidney stone patients

Contact Info

Product

Resources

About